Total Birth Control Market Size, Share, Growth, Trends, and Global Industry Analysis: By Method (Hormonal Intrauterine Device, Copper Intrauterine Device, Combination Oral Contraceptives, Progestin Only Oral Contraceptives, Injectable Contraceptives, Birth Control Implants, Vaginal Rings, Diaphragms, Male Condoms, Female Condoms, and Others), By End User (Hospitals, Gynaecology Clinics, Community Health Care Centers, Online Channel, Public Channel, and Others) and Region Forecast 2019 - 2030

Total Birth Control Market size was valued at US$ x billion in 2023 and is poised to grow at a significant CAGR of 6% from 2024 - 2030.  The World Health Organization (WHO) estimates that 16 million girls between the ages of 15 and 19 give birth yearly, or about 11% of all births worldwide. Its Your Life, It's Your Future by the WHO and World Contraception Day are only two examples of international awareness campaigns that have been started to stop these unintended pregnancies. Governments, international organizations, and other private sector organizations were asked to commit to increasing access to voluntary family planning during the London Summit on Family Planning. Family Planning 2020, a global alliance, was born out of this (FP2020). Global momentum has been generated by FP2020 on topics like access to contraception, more innovation, and improved accountability in family planning initiatives.

For instance, India will have spent US$ 3 billion by 2020 to increase family planning and knowledge in the nation. Additionally, the United Nations Department of Economic and Social Affairs estimates that 1.1 billion women between the ages of 15 and 49 will need family planning worldwide in 2020. The increased use of contraception has improved health-related outcomes, including maternal and infant mortality, and decreased the risk of sexually transmitted infections. In addition, a rise in the number of gynecologists using these contraceptive methods for birth control is anticipated to drive industry growth in the ensuing years.

Increased usage of safe and effective oral pills, awareness of modern contraceptives, and health issues associated with teen pregnancies all contribute to the market forecasts for contraceptives. Significant businesses, including Cooper Companies, Veru Inc., Pfizer Inc., and others, are implementing the acquisition strategy to sustain competitiveness in the market. For example, in March 2021, Cooper finalized the acquisition of a privately held medical device firm that created and developed an innovative obstetric product for use in urgent obstetrics to lower birthing risks, which is likely to generate a market opportunity for contraceptives.

Key Developments:

• In January 2020, Sandoz acquired the Aspen's Japanese operations, strengthening its position in world’s third largest market for generics and off-patent medicines and it also expand portfolio and pipeline of hospital generic and biosimilar products
• In Japan, In May 2020, AbbVie acquired Allergan company, Allergan is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. AbbVie's existing product portfolio and pipeline is enhanced with numerous Allergan assets and Allergan's product portfolio benefits from AbbVie's commercial strength, expertise and international infrastructure.